Using SMD alone to screen older patients for geriatric assessment requires improvement. High-sensitivity cut-off points could miss 11-24% of patients with frailty, and many non-frail patients may be flagged. Screening with SMD is practical but work is needed to understand clinical andresource impacts of different cut-off points. Future research should evaluate performance with additional clinical data and in subgroups.
Keyphrases
- skeletal muscle
- end stage renal disease
- community dwelling
- ejection fraction
- type diabetes
- healthcare
- newly diagnosed
- chronic kidney disease
- physical activity
- palliative care
- insulin resistance
- prognostic factors
- squamous cell carcinoma
- papillary thyroid
- high throughput
- electronic health record
- big data
- adipose tissue
- pain management
- artificial intelligence
- chronic pain